Ledger.Open graph →

SEC Form D · filed June 6, 2018

SUTRO BIOPHARMA INC

Offering

$60.0M

Sold

$31.6M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SOUTH SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Michael G. Ross · South San Francisco, CADirector Daniel J. Janney · South San Francisco, CADirector Bryan G. Lawlis · South San Francisco, CADirector Armen G. Shanafelt · Austin, TXDirector Joseph G. Lobacki · South San Francisco, CADirector William J. Newell · San Francisco, CAExec · Director John G. Freund · San Jose, CADirector Jennifer M. Appleton · Los Gatos, CADirector Martin Beaulieu · La Jolla, CADirector William M. Appleton · Los Gatos, CADirector Matt Osborne · La Jolla, CAExec · Director Ryan L. Hanks · Charlotte, NCDirector Neil F. Dyer · Charlotte, NCDirector David A. Fredston · Santa Monica, CADirector Bruno H. Adoric · Santa Monica, CADirector Daniel M. Hirschfeld · Solon, OHDirector Joseph N. Marconi · Boston, MADirector Michael M. Epstein · Boston, MAExec · Director Daniel W. Cummings · Boston, MADirector Bryan G. Lawlis · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗